Latest Iperionx (ASX:IPX) News

Small-cap shares delivered the week’s biggest moves, led by Mamba’s exploration funding and Cettire’s rebound. Clinical failures, cash shortages and delayed projects kept the broader market cautious.

IperionX has moved its Virginia titanium operation into 24/7 production, lifting nameplate powder capacity to about 200 tonnes a year while commissioning equipment aimed at higher-value components. The progress came alongside a US$66.8 million annual loss, US$63.5 million of operating and investing cash outflows, and continued reliance on government support, customer qualification and future capital.

Small-cap resources led the week, while takeover offers and defence contracts added support across the market.
Investors still had to weigh approvals, cash needs and project delivery against strong headline results.

IperionX says its GenX continuous titanium furnace processed more than 500 kilograms of powder while using substantially less power, magnesium and hydrogen than batch HAMR production. The results strengthen the case for an industrial-scale line, although further optimisation and engineering work are still required.

IperionX has landed a second U.S. Army task order worth US$11.5 million to expand its industrial-scale titanium manufacturing capacity in Virginia, advancing its integrated powder-to-part platform for defense applications.

Materials shares delivered another strong week, led by a 60.61% rise at iTech Minerals and major gains across gold, copper and critical minerals.
Investors rewarded fresh drilling results, larger mineral resources, project approvals and new supply agreements, although several heavily sold stocks showed that early buying did not always last.

IperionX plans to relocate its parent company to Texas and list directly on Nasdaq, aligning its corporate structure with its US operations. The appointment of manufacturing veteran Michael J. Loparco aims to bolster the company’s industrial scale-up.

IperionX reports steady ramp-up of titanium powder output at Virginia facility, successful commissioning of major powder metallurgy equipment, and progress in customer product development. The Titan DFS confirms strong project economics, while the Atlas acquisition broadens critical mineral resources and infrastructure.

IperionX has secured approximately US$50 million through a public offering of American Depositary Shares, targeting the scale-up of its titanium production and expansion of key US facilities.

A tiny gold explorer, a battery materials stock and a biotech name led a week packed with dealmaking, drilling news and fresh funding. Resources did most of the heavy lifting, while several big gaps either held firm or gave back part of their early jump.

Speculation ran hottest in junior resources, where drilling hits, study results and funding deals drove some extreme weekly moves. Rare earths, gold and dealmaking set the pace, while several capital raisings and acquisitions produced mixed reactions.

IperionX has bolstered its U.S. critical minerals footprint by acquiring the Camden assets adjacent to its Titan Project, unveiling surface stockpiles with up to 23% Total Heavy Minerals, up to 10 times Titan’s average grade, and established infrastructure that could accelerate domestic supply chains for titanium and rare earths.